Ubs Asset Management Americas Inc Harmony Biosciences Holdings, Inc. Transaction History
Ubs Asset Management Americas Inc
- $477 Billion
- Q2 2025
A detailed history of Ubs Asset Management Americas Inc transactions in Harmony Biosciences Holdings, Inc. stock. As of the latest transaction made, Ubs Asset Management Americas Inc holds 131,124 shares of HRMY stock, worth $3.55 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
131,124
Previous 95,389
37.46%
Holding current value
$3.55 Million
Previous $3.17 Million
30.9%
% of portfolio
0.0%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding HRMY
# of Institutions
290Shares Held
46.3MCall Options Held
316KPut Options Held
69.9K-
Valor Management LLC Chicago, IL6.62MShares$179 Million88.32% of portfolio
-
Black Rock Inc. New York, NY5.84MShares$158 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.11MShares$138 Million0.0% of portfolio
-
State Street Corp Boston, MA1.63MShares$44.1 Million0.0% of portfolio
-
Dimensional Fund Advisors LP Austin, TX1.58MShares$42.8 Million0.01% of portfolio
About Harmony Biosciences Holdings, Inc.
- Ticker HRMY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,161,400
- Market Cap $1.6B
- Description
- Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...